Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-16-010890
Filing Date
2016-02-16
Accepted
2016-02-16 11:49:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7043215_13g-a.htm SC 13G/A 155558
  Complete submission text file 0000919574-16-010890.txt   157453
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Subject) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-57843 | Film No.: 161425054
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

EIN.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A